MarketCap
Facebook
X
Telegram
Harrow Health ROE Ratio | HROW
Annual ROE Ratio Harrow Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.8 | -25.1 | -34.5 | -51.05 | -159.55 | -12.51 | 0.61 | 59.09 | -458.32 | -296.75 | 1147.94 | -124.15 | -50.58 | -53.85 | 56.11 | 243.8 | -788.9 | -72.28 | -122.75 | 143.9 | 197.83 | 311.51 | 377.23 | 478.15 | 1068.16 | 1921.13 | 5100.0 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5100.0 | -788.9 | 327.61 |
Quarterly ROE Ratio Harrow Health
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -115.42 | -26.59 | -39.89 | -72.48 | -40.98 | -46.8 | -58.66 | -78.39 | -55.86 | -805.74 | -915.58 | -921.45 | -890.59 | -941.89 | -202.85 | -86.41 | -61.37 | -29.59 | 20.84 | -15.8 | -16.58 | -57.96 | -98.32 | -56.46 | -8.98 | -19.14 | 32.44 | 26.83 | -14.16 | -231.83 | -164.92 | -366.55 | -352.35 | -412.21 | -266.67 | -393.32 | -201.88 | 83.46 | 412.63 | 708.08 | 777.98 | 747.89 | 430.7 | 132.86 | -90.47 | -104.21 | -88.81 | -66.65 | -38.13 | -50.59 | -49.9 | -49.02 | -39.32 | -34.3 | -12.16 | 26.33 | 40.13 | 5.02 | 9.67 | 25.43 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 777.98 | -941.89 | -86.85 |
ROE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ProPhase Labs
PRPH
|
-420.27 | - | - | $ 5.07 M |  USA |
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-76.05 | - | - | $ 36.6 M | USA |
 |
HEXO Corp.
HEXO
|
-342.25 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-53.8 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-83.89 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-91.16 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | USA |
 |
OrganiGram Holdings
OGI
|
-14.85 | $ 0.93 | 1.64 % | $ 88.6 M | Canada |
 |
Athenex
ATNX
|
1589.72 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-102.58 | $ 1.14 | -1.72 % | $ 1.92 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
Cronos Group
CRON
|
-0.27 | $ 2.81 | 2.55 % | $ 1.08 B | Canada |
 |
TherapeuticsMD
TXMD
|
-2.12 | $ 2.06 | - | $ 23.8 M | USA |
 |
Jupiter Wellness
JUPW
|
-194.84 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
Canopy Growth Corporation
CGC
|
-37.69 | $ 0.89 | -1.82 % | $ 265 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
-5.67 | $ 6.61 | -5.37 % | $ 98.2 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-34.11 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
-32.33 | - | - | $ 150 M | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
53.37 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | USA |
 |
Zomedica Corp.
ZOM
|
-70.94 | - | -0.21 % | $ 98 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
Perrigo Company plc
PRGO
|
-48.56 | $ 10.09 | -0.1 % | $ 1.4 B | USA |
 |
Bausch Health Companies
BHC
|
-28.34 | $ 4.43 | -0.45 % | $ 1.64 B | Canada |
 |
Emergent BioSolutions
EBS
|
10.07 | $ 7.26 | -3.2 % | $ 388 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.02 | $ 1.52 | -18.28 % | $ 6.52 M |  China |
 |
Aurora Cannabis
ACB
|
0.26 | $ 2.67 | -0.74 % | $ 146 M | Canada |
 |
SCYNEXIS
SCYX
|
-17.44 | $ 3.73 | -5.81 % | $ 186 M | USA |
 |
Evolus
EOLS
|
223.5 | $ 5.98 | -0.17 % | $ 386 M | USA |
 |
Rockwell Medical
RMTI
|
-14.37 | $ 6.63 | 1.61 % | $ 239 M | USA |
 |
Solid Biosciences
SLDB
|
-96.84 | $ 7.83 | -1.88 % | $ 685 M | USA |
 |
Relmada Therapeutics
RLMD
|
-66.33 | $ 5.18 | -0.38 % | $ 205 M | USA |
 |
Veru
VERU
|
-123.97 | $ 2.25 | -2.6 % | $ 33 M | USA |
 |
Organogenesis Holdings
ORGO
|
12.33 | $ 2.39 | -1.65 % | $ 303 M | USA |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 25.88 | -0.19 % | $ 1.2 B | USA |
 |
Sundial Growers
SNDL
|
-1.43 | $ 1.25 | -0.4 % | $ 323 M | Canada |
 |
cbdMD
YCBD
|
-28.24 | $ 0.54 | -6.6 % | $ 2.17 M | USA |
 |
Tilray
TLRY
|
-43.81 | $ 3.88 | -2.76 % | $ 2.4 B | Canada |